Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?

Chia-Chia Liu, Xiao-Song Wang
Author Information

Abstract

No abstract text available.

Keywords

References

  1. Trends Cancer. 2016 Sep;2(9):475-484 [PMID: 28210711]
  2. Noncoding RNA. 2021 Feb 04;7(1): [PMID: 33557176]
  3. Cancer Discov. 2012 Jul;2(7):598-607 [PMID: 22719019]
  4. Nat Commun. 2014 Aug 07;5:4577 [PMID: 25099679]
  5. Oncotarget. 2017 Mar 7;8(10):16843-16850 [PMID: 28186972]
  6. Clin Cancer Res. 2021 Feb 1;27(3):785-798 [PMID: 33172895]
  7. Breast Cancer Res. 2020 Aug 8;22(1):84 [PMID: 32771039]
  8. Genes Chromosomes Cancer. 2022 May;61(5):261-273 [PMID: 35106856]
  9. Genome Biol. 2022 Dec 27;23(1):268 [PMID: 36575460]
  10. Front Cell Dev Biol. 2021 Feb 09;9:623809 [PMID: 33634124]
  11. Breast Cancer Res Treat. 2014 Jul;146(2):287-97 [PMID: 24929677]
  12. Proc Natl Acad Sci U S A. 2020 May 5;117(18):9912-9921 [PMID: 32321829]
  13. Nature. 2007 Aug 2;448(7153):561-6 [PMID: 17625570]

Grants

  1. R01 CA181368/NCI NIH HHS
  2. R01 CA183976/NCI NIH HHS
  3. R21 CA237964/NCI NIH HHS

MeSH Term

Humans
Female
Breast Neoplasms
Breast

Word Cloud

Created with Highcharts 10.0.0luminalbreastcis-splicedfusionproteinspathologicalaggressivecancer?MEKinhibitorRAD51AP1-DYRK4chimericaltranscriptBcancer

Similar Articles

Cited By